Arvid Carlsson: An Early Pioneer in Translational Medicine

被引：5

作者：

Andersen, Julie K. ^{[1
]}

机构：

[1] Buck Inst Res Aging, Novato, CA 94949 USA

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2009年 / 1卷 / 02期

关键词：

ANTAGONISTS;

D O I：

10.1126/scitranslmed.3000149

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Translational medicine has recently experienced an upsurge in interest and funding, yet the idea is not new. More than half a century ago, the Swedish scientist Arvid Carlsson performed basic research on the neurotransmitter dopamine that was rapidly translated into the first clinical treatment for Parkinson's disease. For his contributions, Carlsson shared the Nobel Prize in Physiology or Medicine in the year 2000.

引用

页数：2

共 13 条

[1]

BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[2] 3,4-DIHYDROXYPHENYLALANINE AND 5-HYDROXYTRYPTOPHAN AS RESERPINE ANTAGONISTS [J].